Menstrual Cycle-Synced Neuromuscular Training
Launched by SOPHIA ULMAN · May 13, 2025
Trial Information
Current as of July 12, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Healthy, female high school athlete who participate in running/pivoting sports (e.g., soccer and basketball)
- • Aged 13-19 years
- • Participants must also have a mobile phone, personally or via a parent, capable of downloading the Oura Ring app and of syncing to a wearable device via Bluetooth.
- • Participants will not be excluded from participation if they report irregular periods (not a typical 28-day cycle) or use of hormonal birth control.
- Exclusion Criteria:
- Participants will be excluded from enrollment if they:
- • Have been diagnosed with any musculoskeletal or neuromuscular condition that would impact their movement patterns or training performance
- • Report not yet starting their menses or not currently menstruating (no period in the prior 3 months).
- • Females in the general student body who are not an active participant of the school's soccer or basketball program will be excluded from the study.
- • Participants will be withdrawn if they become pregnant during the course of the study.
About Sophia Ulman
Sophia Ulman is a leading clinical trial sponsor dedicated to advancing medical research and innovation through the development of cutting-edge therapies. With a commitment to enhancing patient outcomes, the organization collaborates with healthcare professionals, regulatory bodies, and research institutions to design and execute rigorous clinical trials across various therapeutic areas. By leveraging a patient-centered approach and employing state-of-the-art methodologies, Sophia Ulman aims to contribute to the advancement of science and improve the quality of life for individuals affected by diverse health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Frisco, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported